High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial

Taylor and Francis Group, Leukemia & Lymphoma, 5(55), p. 1206-1208

Journal article published in 2013 by Anna Laurell, Arne Kolstad, Mats Jerkeman, Riikka Raty, Christian H. Geisler

This paper is available in a repository.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by